Cisplatin and paclitaxel
WebSep 27, 2024 · Markman M, Bundy BN, Alberts DS, et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern … WebConclusion: Chemoradiotherapy using paclitaxel liposome and cisplatin is a well-tolerated and effective treatment regimen for locally advanced ESCC. Keywords: chemoradiotherapy; esophageal squamous cell carcinoma; paclitaxel liposome. © 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. MeSH terms
Cisplatin and paclitaxel
Did you know?
WebThe patient was started on gemcitabine, cisplatin, and nano-particle albumin‐bound paclitaxel (nab‐paclitaxel). After 3 months of chemotherapy, the patient's AFP increased to 43.8 ng/ml and her CA 19‐9 increased to 21.4 U/ml. On repeat CT scan, the size of the tu-mor was stable, but there was suspected intraductal extension to- WebIn the cisplatin plus paclitaxel regimen, IIQ-7 and UDI-6 scores were significantly worse between pre-treatment and mid-treatment; however, there was a tendency for an im-provement in scores from mid-treatment to post-treatment. The SS score significantly improved from mid-treatment to
WebApr 12, 2024 · The recently published TOPAZ-1 phase 3 trial (ClinicalTrials.gov identifier NCT03875235) compared cisplatin and gemcitabine combined with durvalumab.5The data demonstrated that the addition of durvalumab improved OS, PFS, and the objective response rate among patients with unresectable or metastatic BTCs.5In September … WebIn a clinical trial reported by Fan et al, in which 77.1% of the population had stage III esophageal cancer, the ORR for all patients who received two cycles of nab-paclitaxel plus cisplatin chemotherapy was 65.7%. 11 Similarly, in a study of 33 patients with recurrence or metastasis of advanced esophageal cancer, a radiographic response was ...
WebPaclitaxel and cisplatin are two representative chemotherapeutic agents for lung cancers, which induce apoptosis via different action mechanisms. However, it remains unclear … WebChemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis - PMC Back to Top Skip to main content An official website of the United States government Here's how you know The .gov means it’s official. Federal government websites often end in .gov or .mil.
WebAug 1, 2024 · Cisplatin and paclitaxel are associated with improved progression-free survival compared to cisplatin alone during interval debulking surgery with hyperthermic …
jesus moreno sanz maria zambranoWebMay 17, 2012 · Carboplatin and cisplatin, alone or in combination with paclitaxel, have similar efficacies against ovarian cancer (OVCA) yet exhibit different toxicity profiles. jesus moreno youtubeWebIn the present 25-patient study, the MTD of cisplatin tested in the phase 1b portion was 25 mg/m 2. The phase 2 dosing administered to 22 of 25 patients was nab paclitaxel, 125 mg/m 2, cisplatin 25 mg/m 2, and gemcitabine 1000 mg/m 2 given on days 1 and 8 of a 21-day cycle. Tolerance of therapy was acceptable, with nearly two-thirds of patients ... lampkin murderWebOct 5, 2014 · The combination chemotherapy with paclitaxel, cisplatin and fluorouracil is an active and tolerable as first-line and second line therapy in Chinese patients with advanced gastric and esophagogastric junction adenocarcinoma which showed a better tolerance has also been reported (Kim, Shin et al., 1999) jesus morentinWebPatients who underwent primary and interval cytoreduction received a single dose of IP chemotherapy for 24 hours after being divided into four groups: group A, IP cisplatin; group B, IP paclitaxel; group C, IP paclitaxel and cisplatin; and group D, saline. Pre- and postperitoneal IP cytology was assessed along with possible complications. lamp kinderkamer maanWebNov 13, 2013 · Cisplatin and paclitaxel are active in triple-negative breast cancer (TNBC). Despite different mechanisms of action, effective predictive biomarkers to preferentially … lamp kinderkamer kwantumWebMar 9, 2024 · The systemic exposure to cisplatin and paclitaxel was determined and compared to previously published exposure data after intravenous administration. … lampking spectrum.net